The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 20, 2021

Filed:

Dec. 08, 2016
Applicant:

Mayo Foundation for Medical Education and Research, Rochester, MN (US);

Inventors:

Sahil Khanna, Rochester, MN (US);

Purna C. Kashyap, Rochester, MN (US);

Darrell S. Pardi, Rochester, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/689 (2018.01); G01N 33/569 (2006.01); A61K 31/4164 (2006.01); A61K 31/7048 (2006.01); A61K 38/17 (2006.01); A61K 35/74 (2015.01);
U.S. Cl.
CPC ...
C12Q 1/689 (2013.01); A61K 31/4164 (2013.01); A61K 31/7048 (2013.01); A61K 35/74 (2013.01); A61K 38/1774 (2013.01); G01N 33/56911 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/118 (2013.01); G01N 2333/33 (2013.01); G01N 2800/52 (2013.01);
Abstract

Provided herein are biomarkers that can be altered in the gut of a mammal having CDI. One or more biomarkers can be used to predictinfection (CDI) treatment outcome (e.g., response to primary CDI treatment and/or risk of recurrence after primary CDI treatment) in a mammal (e.g., a human) having CDI. Methods for using one or more biomarkers can be used to predict response to primary CDI treatment in a mammal having CDI. Methods for using one or more biomarkers can be used to predict risk of recurrence in a mammal having CDI. Also provided are methods of treating CDI.


Find Patent Forward Citations

Loading…